SHMT2 and breast carcinoma: In addition, elevated median and tertile expression levels of four out of the five genes in the 5-gene metabolic signature, TALDO1, GPI, LDHA, and SHMT2 may provide benefit as individual prognostic predictors in breast cancer (Supplementary Fig. 9).